참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Uracil | HCID 1174 | — |
| 반응물 | Potassium Carbonate | HCID 11430 | — |
| 반응물 | 1,3-Dioxane, 5-(2-bromoethyl)-2,2-dimethyl- | HCID 178988 | — |
| 용매 | Dimethylformamide | HCID 6228 | — |
| 생성물 | 1-[2-(2,2-Dimethyl-1,3-dioxan-5-yl)ethyl]uracil | HCID 57838979 | 29.2% |
반응 단계
To a solution of 5-(2-bromoethyl)-2,2-dimethyl-1,3-dioxane (15) (M. R. Harnden et al, J. Med. Chem., 30, 1636, 1987) (12.0 gm, 53.81 mmol) in dry DMF (150 ml) were added uracil (7.0 gm, 62.4 mmol) and potassium carbonate (14.0 gm). The reaction mixture was stirred at 25° C. for 5 days. The resulting solution was filtered and the solvent removed. The residue obtained was purified by column chromatography on silica gel eluting with chloroform-methanol (90:10, v/v) to afford 17 (4.0 gm, 25.2%).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US07589077B2 |
|---|
| 출처 데이터셋 | uspto-grants-2009_09 |
|---|
| ORD ID | ord-dadfa1e4456d4d92a61eb34f1130e36d |
|---|
| 출처 메모 | uspto-grants-2009_09 |
|---|